- Home
- KRO vs LAB Comparison
KRO vs LAB Comparison
Compare KRO & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRO
- LAB
- Stock Information
- Founded
- KRO 1916
- LAB 1999
- Country
- KRO United States
- LAB United States
- Employees
- KRO N/A
- LAB N/A
- Industry
- KRO Major Chemicals
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- KRO Industrials
- LAB Industrials
- Exchange
- KRO Nasdaq
- LAB Nasdaq
- Market Cap
- KRO 590.2M
- LAB 504.2M
- IPO Year
- KRO N/A
- LAB 2011
- Fundamental
- Price
- KRO $4.35
- LAB $1.14
- Analyst Decision
- KRO Strong Sell
- LAB Hold
- Analyst Count
- KRO 2
- LAB 2
- Target Price
- KRO $6.50
- LAB $1.35
- AVG Volume (30 Days)
- KRO 302.8K
- LAB 1.6M
- Earning Date
- KRO 11-06-2025
- LAB 11-04-2025
- Dividend Yield
- KRO 4.54%
- LAB N/A
- EPS Growth
- KRO N/A
- LAB N/A
- EPS
- KRO N/A
- LAB N/A
- Revenue
- KRO $1,864,200,000.00
- LAB $169,737,000.00
- Revenue This Year
- KRO N/A
- LAB N/A
- Revenue Next Year
- KRO $6.29
- LAB N/A
- P/E Ratio
- KRO N/A
- LAB N/A
- Revenue Growth
- KRO 0.01
- LAB 79.77
- 52 Week Low
- KRO $4.08
- LAB $0.92
- 52 Week High
- KRO $12.92
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- KRO 28.44
- LAB 39.57
- Support Level
- KRO $4.61
- LAB $1.12
- Resistance Level
- KRO $4.79
- LAB $1.25
- Average True Range (ATR)
- KRO 0.20
- LAB 0.08
- MACD
- KRO -0.01
- LAB -0.02
- Stochastic Oscillator
- KRO 18.70
- LAB 17.57
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.